Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer

Anne-Sofie Schrohl Rasmussen; Marion E. Meijer-van Gelder; Mads N. Holten-Andersen; Ib Jarle Christensen; Maxime P. Look; Henning T. Mouridsen; Nils Brünner; John A. Foekens

doi:10.1158/1078-0432.CCR-06-0950

Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer

Anne-Sofie Schrohl Rasmussen, Marion E. Meijer-van Gelder, Mads N. Holten-Andersen, Ib Jarle Christensen, Maxime P. Look, Henning T. Mouridsen, Nils Brünner, John A. Foekens

59 Citations (Scopus)

Original language	English
Journal	Clinical Cancer Research
Volume	12
Issue number	23
Pages (from-to)	7054-7058
Number of pages	5
ISSN	1078-0432
DOIs	https://doi.org/10.1158/1078-0432.CCR-06-0950
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.CCR-06-0950

Cite this

Rasmussen, A-S. S., Meijer-van Gelder, M. E., Holten-Andersen, M. N., Christensen, I. J., Look, M. P., Mouridsen, H. T., Brünner, N., & Foekens, J. A. (2006). Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer. Clinical Cancer Research, 12(23), 7054-7058. https://doi.org/10.1158/1078-0432.CCR-06-0950

Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer. / Rasmussen, Anne-Sofie Schrohl; Meijer-van Gelder, Marion E.; Holten-Andersen, Mads N. et al.

In: Clinical Cancer Research, Vol. 12, No. 23, 2006, p. 7054-7058.

Research output: Contribution to journal › Journal article › Research › peer-review

Rasmussen, A-SS, Meijer-van Gelder, ME, Holten-Andersen, MN, Christensen, IJ, Look, MP, Mouridsen, HT, Brünner, N & Foekens, JA 2006, 'Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer', Clinical Cancer Research, vol. 12, no. 23, pp. 7054-7058. https://doi.org/10.1158/1078-0432.CCR-06-0950

@article{e15bc1f0a1c111ddb6ae000ea68e967b,

title = "Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer",

author = "Rasmussen, {Anne-Sofie Schrohl} and {Meijer-van Gelder}, {Marion E.} and Holten-Andersen, {Mads N.} and Christensen, {Ib Jarle} and Look, {Maxime P.} and Mouridsen, {Henning T.} and Nils Br{\"u}nner and Foekens, {John A.}",

year = "2006",

doi = "10.1158/1078-0432.CCR-06-0950",

language = "English",

volume = "12",

pages = "7054--7058",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research (A A C R)",

number = "23",

}

TY - JOUR

T1 - Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer

AU - Rasmussen, Anne-Sofie Schrohl

AU - Meijer-van Gelder, Marion E.

AU - Holten-Andersen, Mads N.

AU - Christensen, Ib Jarle

AU - Look, Maxime P.

AU - Mouridsen, Henning T.

AU - Brünner, Nils

AU - Foekens, John A.

PY - 2006

Y1 - 2006

U2 - 10.1158/1078-0432.CCR-06-0950

DO - 10.1158/1078-0432.CCR-06-0950

M3 - Journal article

C2 - 17114213

SN - 1078-0432

VL - 12

SP - 7054

EP - 7058

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 23

ER -